Dendritic cells and vaccinations that target a specific molecule on the surface of tumour cells are two examples of the types of treatments now under study for brain tumours.

Brain tumours are becoming more common in Indians of all ages. Each year, more cases are documented. Without prompt diagnosis and treatment, a brain tumour almost always has deadly consequences.

Tumors of the brain are growths or masses made up of malignant cells. The tumours in the brain can be either benign or malignant (malignant). Primary brain tumours form in the brain, but secondary brain tumours originate elsewhere in the body and spread to the brain (metastatic brain tumours).

A brain tumor's telltale signs

Symptoms of a brain tumour are very context-specific, changing in response to the tumor's size, location, and growth pace. The following are some of the more common symptoms associated with a brain tumour:

• Alterations to the usual pattern of headaches
• The gradual and steady increase in the frequency and intensity of one's headaches
• No identifiable trigger for the vomiting or nausea
• Problems with one's eyesight, such as being unable to focus, seeing double, or losing their peripheral vision
• Loss of feeling and function in one's arms and legs.
• issues with equilibrium
• speech impairment
• Tiredness Confusionism in regular life
• It's tough to make a call.
• Failure to understand basic instructions
• Alterations in character or conduct
• Convulsions, particularly in someone without a prior history of them
• Issues with hearing
• Don't wait to see a doctor if worrying symptoms keep cropping up.

Recent Developments in Brain Tumor Treatment

The availability of treatment depends on the specific characteristics of the brain tumour, such as its size, location, and kind. Researchers are trying to figure out what causes brain tumours, what treatments work best, and how to best care for patients who have been diagnosed with such a disease. New diagnostic and therapeutic options for patients have emerged in the following areas thanks to various clinical trials: Improved imaging tests may help doctors monitor for tumour growth or recurrence and gauge the efficacy of treatment.

Tests for biomarkers are now being studied to see if they can aid in the identification of a brain tumour, the estimation of a patient's prognosis, or the prediction of the efficacy of a specific treatment. A biomarker is a diagnostic indicator typically extracted from bodily fluids or cells. The results of biomarker tests can help the doctor learn more about the disease.

Immunotherapy, also known as biological response modifier (BRM) therapy, is used to stimulate the immune system to increase tumor-fighting capabilities. Improving, targeting, or restoring immune system function using materials produced by the body or in a laboratory.

Multiple approaches are being studied for the treatment of brain tumours. These include the use of dendritic cells and vaccinations that target a specific chemical on the tumour cells' surface.

The use of a virus that specifically targets tumour cells while avoiding normal brain tissue is at the heart of oncolytic virus therapy. As a possible treatment for brain tumours, it is now under investigation.

In targeted therapy, the defective genes or proteins responsible for tumour growth and development are eliminated. Researchers are exploring several treatment options for brain tumours in an effort to eliminate the tumour at its source rather than just trying to stop it from growing and spreading.

By temporarily disabling the brain's natural protective barrier, called the blood-brain barrier, this method facilitates the entry of chemotherapy into the brain via the bloodstream.

There are new medications and drug combinations being considered for the treatment of brain tumours, and some of these drugs are already in use for the treatment of other types of cancer. Tumors can become resistant to chemotherapy, rendering it ineffective, hence another strategy is to employ a treatment that targets the mechanism through which tumour cells become resistant.

Gene therapy is a type of cancer treatment that tries to replace or repair faulty genes that are directly responsible for, or contribute to, tumour development.

Brain tumour risk and progression may be related to certain gene alterations, which can be studied through genetic research. In order to better understand the glioma-gene connection, researchers at the National Institutes of Health in the United States are hard at work. The genes NF1, ERBB2, and PIK3R1 have all been found to have mutations that increase susceptibility to glioblastoma, which is a rare form of brain cancer. Mutations in the IDH and MGMT genes may also contribute to the development of brain tumours, a topic being investigated in other research. Researchers will find this material helpful, and it may lead to new discoveries and methods for diagnosing and treating gliomas.

Care for the dying and the chronically ill There are ongoing clinical trials being conducted to investigate more effective ways of alleviating the symptoms and adverse effects of current brain tumour treatments.

The inability of medications to pass the blood-brain barrier has been a major obstacle in the treatment of these aggressive tumours. Chemotherapy and radiation therapy are two examples of treatments that can penetrate the blood-brain barrier, although their usage is often restricted due to their hazardous effects. Some individuals cannot undergo surgery or other conventional treatments because of the location of the tumour.

The development of safe and effective treatments for malignant brain tumours is the field's current grand challenge. Scientists are working hard to create more potent medicines. The future of brain tumour treatment has promise, with the introduction of clinical trials and innovative methods.

Information Doctor Profile : www.vasavihospital.in